Nuvilex, Inc. a Biotech Developing Treatments for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Nuvilex, Inc. a Biotech Developing Treatments for Healthcare's Hard Targets

NEW YORK, NY--(Marketwired - Jun 26, 2013) - Nuvilex, Inc. ( OTCQB : NVLX ) executives aren't daunted by the statistics. As a matter of fact, they're aware the research they do is directed towards attacking what the company's Chief Operations Officer, Dr. Gerald Crabtree, calls two of cancer's "hard targets." "Pancreatic cancer and brain cancers represent two such targets. Pancreatic cancer because it doesn't present overt symptoms until the cancer is at an advanced stage; therefore, it is more difficult to treat effectively, and the result is that the survival of patients with advanced pancreatic cancer is usually only several weeks to a few months. Brain cancers are another hard target because many of our most effective cancer drugs cannot cross the 'blood-brain' barrier to attack the tumor."

Make no mistake about it: the statistics aren't pretty. The American Cancer Society estimates that, in 2013, more than 45,000 people will be diagnosed with pancreatic cancer and over 38,000 will die from the disease in the US alone. It is the fourth most deadly form of cancer in the world and a disease where no amount of money or fame will help change those statistics. Recently it has claimed the lives of well known names like Apple's Steve Jobs, actor Patrick Swayze and Nobel Prize recipient Dr. Ralph Steinman. 

Both pancreatic cancer and cancers of the brain are the hard targets that Nuvilex has invested its research into in order to develop treatments with its cell encapsulation technology and future medical marijuana studies. The company has close to $30 million invested in its unique live-cell encapsulation technology, and it's using that technology, combined with the cancer killing drug ifosfamide, in clinical trials for the treatment of advanced, inoperable pancreatic cancer.

Eli Lilly's Gemzar is the only drug approved by the FDA as a single agent for the treatment of advanced pancreatic cancer, and is the current "gold standard" for the disease. Eli Lilly has enjoyed sales of over $10 billion for the drug for all indications, but Gemzar accounts for the majority of the sales of all drugs for advanced pancreatic cancer.

It is Nuvilex's goal to make an impact on that market with its treatment. Over the years, several drugs have been combined with Gemzar in an effort to improve survival, but these efforts have only been marginally successful. In fact, since 1990, 33 pivotal (for marketing approval) Phase III clinical trials have been conducted -- only 3 were successful.

Continue reading this article at www.stockmarketmediagroup.com/features .

About Stock Market Media Group

Stock Market Media Group is a full service Investment Relations firm specializing in Research and Content Development. It offers a platform for CEOs to tell their story through the media with Research Reports, CEO Interviews and Feature Articles while building a library of Research for Investors to become better informed on small cap companies. For more information: www.stockmarketmediagroup.com

Contact: Stock Market Media Group Email Contact (646) 397-4020

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EASE Unlocks $9.5M for AI Medical Expansion in Africa

Updated Category News Views 8

Transforming Healthcare in South Africa and Ghana Expanding into uncharted territories often requires a leap of faith, and EASE Holdings has just taken a substantial one. The medical equipment-as-a-service provider has grabbed a hefty $9.5 million in equity from AAFC Group Inc. The goal? To flood South Africa and Ghana with cutting-edge medical imaging and surgical...

Continue Reading
TikTok-Coda: A New Era for Digital Commerce

Updated Category News Views 113

Redefining Commerce in the Digital Age Alright, folks, let's chew the fat over something that's flipping the script on digital commerce. Coda, the Southeast Asian powerhouse in digital content monetization, is stirring things up with TikTok Gaming. Since June, it's been cooking up one billion views worth of creative potential from users, tightening the grip on digital...

Continue Reading
Ceva's Wireless IP Dominance Amid AI Device Surge

Updated Category News Views 46

Keeping the Wireless IP Crown Against All Odds Look, I've seen dominance play out in the markets over the years, but Ceva’s stranglehold on the wireless interface IP market is something fierce. They've got a whopping 68% market share, and folks, that’s 12 times their closest competitor. Talk about leaving the competition eating dust! For a field growing at a solid...

Continue Reading
Wujiang Celebrates 90 Years of Fei Xiaotong's Legacy

Updated Category News Views 94

If you thought anniversaries were just about looking back, think again! In Wujiang, November 1st was all about forging ahead. Scholars and local officials weren't just reminiscing about Fei Xiaotong's landmark field study at Jiangcun 90 years ago; they were strategizing how to apply the sociologist's insights to today's economic and community challenges. Marking a Legacy...

Continue Reading
Double Down for Veterans Raises $20 Million Goal

Updated Category News Views 219

Helping Veterans: A Call That Never Fades If there's one thing that never changes, it's the enduring need to support those who have served. Semper Fi & America's Fund has been at the forefront of this mission for over a decade, and their annual Double Down for Veterans Match Campaign is nothing short of a testament to unwavering commitment. Kicking off for the 15th time,...

Continue Reading
TESSAN and Jamie Leibert's Daring Alpine Documentary Launch

Updated Category News Views 308

Steps Beyond the Obvious Adventure Launching headlong into the unknown—literally and figuratively—is what the documentary Jump Into The Unknown captures. TESSAN and Jamie Leibert have peeled back the curtain on adventure, showing us that it’s not just about the destination, but every twist, turn, and recalibrated step in between. The Backstory Behind Every Jump...

Continue Reading
New Era Celebrates Valkyries' Groundbreaking WNBA Win

Updated Category News Views 217

A Surprising Win for a Rising Team In the world of sports, sometimes the odds are defied, and stories of triumph unfold that capture the imagination. The Golden State Valkyries did exactly that by snagging their first WNBA Championship title just a year after entering the league. It's a narrative right out of a Hollywood script—only this time, it's inked in real...

Continue Reading
Perion Acquisition: Affle's Bold Leap in Ad Tech

Updated Category News Views 197

Affle's Strategic Acquisition of Perion Jumpin' through another hoop, Affle is gearing up to snag Perion in a hefty deal valued at about $420 million. For those of you not knee-deep in the ad tech sandbox, Affle—trading on the NSE as AFFLE—is aiming to ramp up its AI-driven conversion game by absorbing Perion, a veteran in the omnichannel advertising realm. "This...

Continue Reading
One Stop Swap eyes school fundraising for growth

Updated Category News Views 122

Transforming Fundraising with a Marketplace Twist Sometimes the real treasures are not tucked in textbooks but found in cluttered closets and basements. Enter One Stop Swap with a big idea—they're cooking up a fundraising strategy for schools that could shake things up by helping families sell their unused stuff. It's got that grassroots vibe with the potential to carve...

Continue Reading
China's Innovation Surge: Game Changer for Global Markets

Updated Category News Views 188

The Bold Shift in China's Economic Landscape Well, here's the scoop: China isn't just the world's assembly line anymore; it's gearing up to be a top-tier innovation hub. On the surface, might seem like another geopolitical spiel, but dig a little and you'll find it's a serious shake-up for global markets. We're talking about more than just products rolling out of...

Continue Reading

Top 5 Most Recently Viewed Articles

Yealink Partners with TÜV SÜD for Enhanced Compliance and Growth

Updated Category News Views 208

Yealink Collaborates with TÜV SÜD for Global Compliance Yealink, the leading provider of unified communication and collaboration solutions, has entered into a significant strategic partnership with TÜV SÜD, a globally recognized authority in testing and certification. This alliance marks an important step in enhancing Yealink's commitment to compliance, product...

Continue Reading
Crocs Faces Setbacks as HEYDUDE Sales Decline, Price Target Adjusted

Updated Category News Views 177

Overview of Crocs' Price Target Adjustment Recently, an update from Williams Trading announced a price target reduction for Crocs (NASDAQ: CROX) from $163 to $140, while still keeping a Buy rating on the company’s stock. This adjustment is attributed to various factors, including a revised outlook on the company's financial performance for the upcoming years....

Continue Reading
Good Times Restaurants Prepares for Q4 Financial Results Call

Updated Category News Views 106

Good Times Restaurants Announces Conference Call for Q4 Results Good Times Restaurants Inc. (Nasdaq: GTIM), known for operating Bad Daddy’s Burger Bar and Good Times Burgers & Frozen Custard, is set to host a conference call discussing its fourth quarter and fiscal results. The call is scheduled for December 12, in the evening. Key executives, including CEO Ryan M. Zink...

Continue Reading
Rubicon Organics Achieves Record Growth in Q1 Financial Results

Updated Category News Views 281

Rubicon Organics Reports Impressive Q1 Financial Growth Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) has recently shared its financial results for the first quarter of 2025, marking a pivotal moment in the company's growth trajectory. The firm reported a net revenue of $12.4 million, showcasing a remarkable increase of 39.2% year-over-year. This strong performance...

Continue Reading
Blue Sky Uranium's Roadmap to Feasibility for Ivana Project

Updated Category News Views 154

Blue Sky Uranium's Strategic Roadmap for the Ivana Deposit Blue Sky Uranium Corp. (TSXV: BSK, OTC: BKUCF) has achieved a significant milestone with the completion of a thorough Gap Analysis for the Ivana Uranium-Vanadium Deposit, located in the Amarillo Grande Project. This analysis lays out a structured approach for advancing the project towards feasibility, making it a...

Continue Reading